New York, NY -- (SBWIRE) -- 12/16/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Globalstar, Inc (OTCMKTS:GSAT), IAMGOLD Corp (USA) (NYSE:IAG), Hovnanian Enterprises, Inc (NYSE:HOV), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Globalstar, Inc (OTCMKTS:GSAT) showed a volume of 6.77 million shares by the end of last trade whereas the average volume of the stock remained 4.38 million shares. The stock opened the session at $2.01 but then moved to $1.97. At that price, the stock showed a negative performance of 1.97%. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation.
Will GSAT Get Buyers Even After The Recent Rally? Find Out Here
IAMGOLD Corp (USA) (NYSE:IAG) opened the session at $3.50 and closed the session at $3.43. The stock showed a positive performance of 0.29% in previous trading session. IAMGOLD Corporation (IAMGOLD) is a mining company. IAMGOLD‘s interests include five operating gold mines, a niobium mine, a diamond royalty, and exploration and development projects located in Africa and the Americas. IAMGOLD is focused in West Africa, select countries in South America and in the Canadian province of Quebec.
For How Long IAG will fight for Profitability? Read This Trend Analysis report
Hovnanian Enterprises, Inc (NYSE:HOV) opened the session at $5.32 and closed the session at $5.37. The stock showed a positive performance of 1.70% in previous trading session. The beta of the stock remained 3.25. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments. The Company consists of two distinct operations: homebuilding and financial services. Its homebuilding operations consist of six segments: Northeast,including New Jersey and Pennsylvania; Mid-Atlantic, including Delaware, Maryland, Virginia, West Virginia, and Washington,
Why Should Investors Buy HOV After The Recent Gain? Just Go Here and Find Out
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) the stock decreased -7.27% and finished the session at $1.02. Traded with volume of 6.26 million shares in the prior session and the average volume of the stock remained 2.44 million shares. The beta of the stock remained 2.71. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)